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Background: In this study, the clinical and morphological features of vesiculobullous lesions observed in Kaposi
sarcoma are analyzed, and the features of bullous Kaposi sarcoma cases are emphasized.
Methods: A total of 178 biopsy materials of 75 cases diagnosed as classic-type cutaneous Kaposi sarcoma were
reviewed. Twenty-five cases showing vesiculobullous features were included in the study. Tumor, epidermis, dermis,
and clinical data regarding these cases was evaluated.
Results: Vesicular changes were observed in 21 (12%) out of 178 lesions of the 75 cases, while bullous changes
were present in only 4 (2%). In all cases where vesicular and bullous changes were detected, tumor, epidermis, and
dermis changes were similar. All cases were nodular stage KS lesions, whereas hyperkeratosis and serum exudation
in the epidermis, marked edema in the dermis, and enlarged lymphatic vessels and chronic inflammatory response
were observed.
Conclusions: Our findings suggest that changes in vascular resistance occurring during tumor progression are the
most important factors comprising vesiculobullous morphology.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1646397188748474
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Kaposi sarcoma (KS) is composed of four different epi-
demiological forms—classic, endemic, iatrogenic, and
AIDS-associated (Acquired Immune Deficiency Syndrome)
etiology comprising HHV-8 (Human Herpes Virus-8) [1].
The most common epidemiological form is the classic
type. KS lesions are markedly different in terms of clinical
picture and histopathological features, therefore many
morphological variants have been defined, e.g., usual
[UKS], anaplastic, telangiectatic, lymphangiectatic, hyper-
keratotic, micronodular, keloidal, intravascular, pyo-
genic granuloma-like [PGLKS], lymphangiectatic [LKS],
lymphangioma-like [LLKS], etc. UKS is the most common
histological subtype, and the progression of the lesions is
characterized by an increase in spindle cells [2-7].* Correspondence: niluferkandemir@yahoo.com
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reproduction in any medium, provided the orBullous KS [BKS] defines KS lesions in which a bullous
appearance is clinically dominant. Bullous changes are
rare in KS, but they are important in that they may
be confused with other vesiculobullous skin disorders.
The evolutionary mechanisms of bullous lesions in
KS are still controversial, including whether or not they
should be assessed as a different morphological subgroup
[7-21].
In this study, the clinical and morphological fea-
tures of vesiculobullous lesions observed in classic
KS are analyzed, and the features of bullous KS
lesions are emphasized in association with the relevant
literature.Methods
Sample selection
The study sample included 178 classic cutaneous KS
cases in 75 patients who were diagnosed in the path-
ology departments of the University of Karaelmas, andral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2001 and 2010. The clinical data was obtained from pa-
tient files. There was no history of immunosuppressive
drug use, transplantation, or human immunodeficiency
virus-1 [HIV-1] infection in any of the patients. All
patients with KS were HIV-1 seronegative. All of the
cases were classified as classic KS.
The study was performed in accordance with the Helsinki
Declaration, and the privacy of the patients was protected
through the decoding of data, according to the privacy reg-
ulations of the Zonguldak Karaelmas University Hospital
(Zonguldak, Turkey), and Dr. Lütfi Kırdar Training and
Research Hospital (İstanbul, Turkey).
Histopathological evaluation
The histopathological diagnoses of all KS cases were
confirmed through the examination of archived
hematoxylin and eosin (H&E) slices, and immunohisto-
chemical survey results. Histological sections of biopsy
materials were assessed in terms of the properties of the
tumors (histological type and stage), epidermis (atrophy,
hyperkeratosis, papillomatous, vesicle and/or bulla,
ulcer), and dermis (edema, inflammatory response, lym-
phangiectasia). Features were graded semi-quantitatively
between 0–3 in a grading of histopathological findings,
i.e., 0 – negative, 1 – mild, 2 – moderate, 3 – marked.
Blisters are fluid-filled cavities located within or be-
neath the epidermis. Blisters equal to or greater than
5 mm are called bullae, whereas blisters smaller than
5 mm are called vesicles. We also used these criteria to
differentiate between vesicles and bullae [22].
The histological progression of KS lesions is composed
of three phases, which can also be detected clinically:
early (patch), intermediate (plaque), and late stages
(nodule). The following criteria have been used to de-
termine the histological stages of lesions:
 Early phase: Lesions which are composed of
inflammatory cells and newly-formed vascular
structures, and contain no spindle cells.
 Intermediate phase: Lesions with scattered spindle
cells and cleft-like structures filled with erythrocytes,
in addition to neoplastic vascular structures.
 Late phase: Lesions in which spindle cells form
nodular structures and blood-filled pseudovascular
structures [1,2].
Immunohistochemical analysis
Immunohistochemical analysis with endothelial indica-
tors (CD31, CD34, D2-40) and HHV-8 (latent nuclear
antigen-1 [LNA-1]) monoclonal antibodies were per-
formed for confirmation of the histopathlogical diagnosis
in each case. Immunohistochemical studies were per-
formed using archival materials. A set of 4-μm-thicktissue sections was prepared from formalin-fixed and
paraffin-embedded blocks, deparaffinized in xylene,
rehydrated, and microwaved for 10 min at 30% power in
a citrate buffer (pH 6.0) for antigen retrieval. Endogen-
ous peroxidase activity was blocked using 0.3% hydrogen
peroxide. The slides were then incubated at room
temperature for 1 hour with D2-40 (1:100 dilution,
Clone D2-40; BioCare Medical, Concord, CA, USA),
CD31 (1:50 dilution, Clone JC/7A; NeoMarkers, Free-
mont, CA, USA), CD34 (1:100 dilution, Clone QBEnd/
10; NeoMarkers), and HHV-8 (LNA- 1) (1:50 dilution,
Clone 13B10; Novocastra, Newcastle, UK), using the
biotin-streptavidin complex-diaminobenzidine (BSA-
DAB) technique for detection. Negative controls were
processed in parallel without primary antibodies. The
D2-40 immunoreactivity of lymphatic endothelial cells,
and the CD31 and CD34 immunoreactivity of capillaries
in the upper dermis were used as internal positive
controls.
Results
Vesiculobullous histomorphology was observed in 25
(14%) out of 178 lesions of 75 cases. Vesicular formation
was detected in 21 (12%) and bullous formation was
detected in 4 (2%) cases in microscopic evaluation. Clin-
ical vesicular changes were not detected in any of lesions
in which vesicular formation microscopically whereas
bullae were detected clinically in all lesions in which bul-
lous formation was detected microscopically (Figure 1).
KS cases showing vesicular changes were present in 15
male (71%) and 6 female (29%) patients, and the mean
age was found to be 72.50 ± 11.09 (min. 35–max. 84). Of
all the lesions, 11 were seen in the lower extremities
(52%), while 6 were in the upper extremities (29%) and 4
on the trunk (19%). All lesions were nodular stage KS
lesions and, when epidermal changes were analyzed,
hyperkeratosis was detected in 100% of the cases, serum
exudation into the keratin layer in 64%, intraepidermal
splitting in 84%, subepidermal splitting in16%, ulceration
in 10%, papillomatous changes in 10%, and a rise in pig-
mentation on the basal membrane in 5%. Marked der-
mal edema and enlarged lymphatic vessels were
observed in all cases, while chronic-type inflammatory
response was seen in 86%. In cases in which ulceration
was observed within the epidermis, neutrophil infiltra-
tion was detected in varying amounts, in addition to
chronic-type inflammatory response (Table 1, Figure 2).
When the histological subgroups of tumors were ana-
lyzed, 4 cases (19%) were assessed as LKS, 16 cases
(76%) as UKS, and 1 case (5%) as PGLKS (Figure 3).
Bullous morphology was observed both clinically and
histopathologically in 4 cases (16%), and these cases
were evaluated as BKS. In cases in which bulla morph-
ology, hence named BKS, was observed clinically, the
Figure 1 Different clinical appearances of lesions in bullous KS: (A) focal vesiculobullous changes in lesions of plaque and nodular
stage, (B) bulla structures showing ulceration in nodular stage lesions, (C) sponge-like vesiculobullous lesions in a generalized KS case
are observed.
Table 1 Clinicopathological features of Kaposi sarcoma





Clinical features Sex Female 6 29
Male 15 71
Head&Neck 0 0













Histological features Papillomatosis 2 10
Atrophy 0 0
Epidermis Pigmentation 1 5
Ulceration 5 24
Vesicle IE 17 84
SE 4 16
Edema 21 100
Dermis Fibrosis 0 0
Inflammation 18 86
Lymphangiectasia 21 100
KS: Kaposi sarcoma, UKS: Usual KS, LKS: Lymphangiectatic KS, PGLKS: Pyogenic
granuloma-like KS, IE: Intraepidermal, SE: Subepidermal.
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72), and the female:male ratio was 1:3. The lesions were
observed on the lower extremities (n = 2), the upper ex-
tremities (n = 1), and the head and neck region (n = 1).
All cases were found to be nodular stage lesions, and
serum exudation into the keratin layer was detected in 4
cases, intraepidermal (IE) and subepidermal (SE) bulla
were detected in 3 and 1 cases, respectively, and ulcer-
ation in 2 cases. Papillomatosis was observed in 1 case
and pigmentation increase in the basal layer was
observed in 2 cases. Atrophy in the epidermal layer was
not displayed in any of the cases. Marked edema,
enlarged lymphatic vessels, and chronic-type inflamma-
tory response were detected in all cases when the dermal
properties were analyzed (Table 2, Figure 4, 5 and 6).
The lesion cells of all KS cases showed various degrees
of CD31, CD34, D2-40 (cytoplasmic), and HHV-8
(LNA-1) (nuclear) immunoreactivities. The non-
neoplastic lymphatic endothelium, lymphangioma-like
channels, proliferative capillaries, and spindle cells were
reactive with D2-40, whereas the non-neoplastic blood
vessels and thick-walled, mature vascular structures were
non-reactive. The reaction was positive in non-
neoplastic blood vessels with CD31 and CD34, while the
non-neoplastic lymphatic vessels were non-reactive.
There was a reaction with CD31 in all cellular compo-
nents forming KS. There was a homogenous reaction
with CD34 in neoplastic capillary structures, and spindle
cells. A diffuse, strong nuclear reaction was observed
with HHV-8 (LNA-1) in neoplastic vascular structures
and spindle cells forming KS.Discussion
KS is classically characterized by blue-purple colored vascu-
lar lesions [1-5]. It is rare that these lesions demonstrate
Figure 2 Hyperkeratosis (A) and serum exudation within keratin layer in epidermis and enlarged lymphatic vessels (B) in superficial
dermis are observed in bullous KS (A-B; H&E, X400).
Kandemir et al. Diagnostic Pathology 2012, 7:101 Page 4 of 9
http://www.diagnosticpathology.org/content/7/1/101vesiculobullous morphology. Although vesiculobullous
changes can be detected in different subgroups of KS, cases
in which bullous changes dominate clinically are named
bullous KS [5-21]. The clinical appearance of lesions in bul-
lous KS can show a tight or collapsed bulla structure,Figure 3 Intraepidermal (A) and subepidermal (B) splitting, superficia
KS (A-B; H&E, X200).ulcerated blister, or sponge-like properties. Marked dermal
edema, intraepidermal or subepidermal splitting, and serum
exudation in the epidermis can be seen histopathologically
in these lesions. Bullous KS has the ability to imitate other
vesiculobullous diseases clinically [7-22].l ulceration and marked dermal edema are observed in bullous
Table 2 Clinicopathological features of Kaposi sarcoma cases showing bullous morphology (n =4)
Clinicopathological features Cases
1. 2. 3. 4.
Age 72 68 70 57
Clinical features Sex M M F M
Location Hand Leg Food Neck
Histological stage Nodular Nodular Nodular Nodular
Histological component UKS LLKS UKS UKS
Hyperkeratosis 2+ 2+ 3+ 1+
Epidermis Papillomatosis 0 0 1+ 0
Atrophy 0 0 0 0
Histological features Pigmentation 1+ 1+ 0 0
Ulceration 2+ 1+ 0 0
Bull IE IE IE SE
Edema 3+ 3+ 3+ 3+
Dermis Fibrosis 0 0 0 0
Inflammation 3+ 2+ 2+ 1+
Lymphangiectasia 3+ 3+ 3+ 2+
KS: Kaposi sarcoma, UKS: Usual KS, LLKS: Lymphangiom-like KS, PGLKS: Pyogenic granuloma-like KS, IE: Intraepidermal, SE: Subepidermal, F: Female, M: Male.
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and Kern in 1957 [11]. To date, 30 reported cases with
different terminologies have been available (Table 3)
[5-21]. Cossu et al. reported bullous KS frequency at 4%Figure 4 Microscopic appearances of a bullous KS: intraepidermal bu
epithelium of a nodular stage KS (A-B; H&E, A, X50, B, X100). Nuclear
composed of extravasated erythrocytes and spindle cells (C; H&E, X400, D;in epidemic KS cases [13]. Notwithstanding, in our series
composed of classic KS cases, vesiculobullous changes
were observed in 14% of all patients, whereas only 2% of
these met the diagnostic criteria of bullous KS. Ourlla structure and serum exudation are observed within squamous



























Figure 6 Histological component of Kaposi sarcoma cases
showing vesiculobullous pattern (n = 25). KS: Kaposi sarcoma,
UKS: Usual KS), LKS: Lymphangiectatic KS, LLKS: Lymphangiom- like
KS, PGLKS: Pyogenic granuloma-like KS.
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suggest that bullous morphology is a rare finding among
KS cases.
Grayson et al. reported that bullous changes were seen
more frequently among classic KS cases [7]. When the
clinical features of reported bullous classic KS cases
were analyzed, it was seen that there was a higher num-
ber of older male patients and that lesions were largely
found in the lower extremities. However, AIDS-related
bullous KS cases can appear at earlier ages, and systemic
involvement plus an aggressive clinical course might be
observed in these cases [14]. In our study, it was found
that 75% of bullous KS patients were male, and that the
age range varied between 57 and 72. Fifty percent of
these lesions were seen in the lower extremities, while
25% were in the upper extremities, and 25% in the head
and neck region. In our series, it was detected that the
demographic data of bullous KS cases was similar to that
of other classic KS cases.
Blister formation in skin lesions develops by various
mechanisms. The best-known mechanisms are spongio-
sis, achantholysis, ballooning degeneration, cytolysis, and
basal membrane destruction. Among the mechanisms
leading to blister formation are extracellular and intra-
cellular edema, physical and chemical agents, infections,
and immunological mechanisms. Spongiosis is the disin-
tegration of keratinocytes because of accumulation of
extracellular fluid in the epidermis. As a result, fluid-
filled vesicles and bullae are formed in some cases.
Spongiotic changes are accompanied by dermal edema,
lymphatic dilatation, and perivascular inflammation [22].
Various theories regarding the etiopathogenesis of
vesiculobullous lesions in KS have been suggested. Some
researchers advocate that these lesions develop over
chronic lymphedema ground, and that it is a specific en-
tity, similar to lymphangioma circumscriptum [6,9,16].
However, some researchers have proposed that thesedermal vascular changes are secondary to the local
effects of tumor tissue and cause vesiculobullous morph-
ology [7,9,14]. Factors inducing the development of bul-
lous lesions in KS include the corruption of lymphatic
drainage by tumor tissue, lymphaticovenous shunts
formed on neoplastic vascular canals, lymphovascular in-
vasion of tumor cells, the involvement of regional lymph
nodes, and/or cytokine release. All of these factors can
cause the development of stasis in cutaneous lymphatic
vessels, dermal edema, and hence the formation of intraepi-
dermal/subepidermal bulla secondary to absorption of
lymphatic liquid by the epidermis [1,14-17,22].
In our series, all of the lesions showing bullous pattern
were nodular stage lesions, and marked edema plus
enlarged lymphatic vessels were observed within the
Table 3 Bullous Kaposi sarcoma: Review of the English-language literature
Refence N Sex (n) Age Nomenclature E. Type Location H. Stage Clinical apperance Association Behavior Year
Ronchese et al. [11] 2 M 68-66 Cystic, LLKS Classic Lower extremity Nodular Bulla-like - Generalized/slow progresion 1957
Gange et al. [21] 3 F (1) 55-72 (63) LLKS Classic Lower and Nodular Bulla-like (1), - Generalized/slow 1979
M (2) upper extremity Papule (1) progresion
Plaque (n = 1)
Leibowitz et al. [18] 1 M 34 LLKS - Lower extremity Nodular Bulla-like Lymphedema Aggressive 1980
Recth et al. [17] 1 F - Bullous Classic Lower extremity Nodular Bulla-like, Vesicular - - 1986
Bossuyt et al. [19] 1 M - LLKS AIDS Lower and upper extremity Nodular Bulla-like Lymphedema Generalized/slow progresion 1995
Perrot et al. [14] 1 M - Bullous AIDS - - Bulla-like Lymphedema Aggressive 1995
Noel et al. [20] 1 M - LLKS AIDS Lower extremity Nodular Sponge-like - Generalized/slow progresion 1997
Cossu et al. [13] 7 F (1) 59-80 (70.3) LLKS Epidemic Lower extremity (6) Nodular Bulla-like (3) - Aggressive (1) 1997
M (6) Upper extremity (1) Sponge-like (4) Generalized/
slow progresion (5)
Localized/ slow progresion (1)
Borroni et al. [8] 1 F 82 Bullous Classic Lower extremity Nodular Bulla-like - - 1997
Cottoni et al. [10] 6 M (4) 56-80 (68.5) LLKS (4) Classic Lower and Nodular Ulcer (2), Lymphedema (4) Aggresive (1) 1997
F (2) Regular (2) upper extremity (2) Bulla-like (1)
Lower extremity (4) Serohematic loss (3)
Davis et al. [12] 4 M 35 Bullous AIDS Lower extremity, scrotum Nodular Bulla-like Lymphedema Aggresive 2000
Atillasoy et al. [16] 1 M 41 Bullous AIDS Lower extremity Nodular Bulla-like, necrotic Lymphedema Aggresive 2001
Torchia et al. [9] 1 M 98 Pseudobullous Classic Lower extremity Nodular - Lymphedema Generalized/slow progresion 2008
Present series 4 M (3) 57-72 (66.7) Bullous Classic Lower and Nodular Ulcer (2), bulla-like - Localized/
F (1) upper extremity (3) (4), serohematic crust slow progresion (3)
Head &Neck (1) Aggresive (1)
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lae were detected in 3 and 1 cases, respectively. In all
cases, serum exudation within the keratin layer was
observed. Lymphedema was not detected clinically in
any of the cases. Our findings suggest that lymphangiec-
tasia and peritumoral edema secondary to tumor play a
vital role in the etiology of bullous KS.
Hyperkeratosis is frequently observed, and in some
cases, necrosis plus ulceration can be seen on the bulla
ceiling in bullous KS cases. Dermal edema and enlarged
lymphatic vessels are prominent in bullous KS cases,
and fibrosis can be observed in those patients who re-
ceive radiotherapy [8-13]. In our study, hyperkeratosis
was observed in all bullous KS cases, and ulceration was
detected in two cases. Edema, enlarged lymphatic ves-
sels, and chronic-type inflammatory response in varying
degrees were observed in the dermis of all cases. Our
findings show that histological findings accompanying
the most frequently-found in bullous KS include hyper-
keratosis, dermal edema, and lymphatic ectasia.
Cossu et al. reported that bullous changes are more
frequent in KS cases showing lymphangioma-like fea-
tures [13]. However, Cottoni et al. advocate that bullous
changes cannot be related to any specific histological
subgroup [10]. Although a large portion of cases
reported in literature showed lymphangioma-like histo-
logical properties, bullous morphology can also be
observed in pyogenic granuloma-like, lymphangiectatic,
or usual-type KS cases. When the histological subgroups
of KS cases with vesicular changes were analyzed in our
study, 76% of all lesions showed usual-type properties,
while 19% showed lymphangiectatic-type and 5% pyo-
genic granuloma-like properties. In one and three out of
four cases assessed as bullous KS, lymphangiectatic- and
usual-type KS properties dominated, respectively.
Vesicular changes (n = 21, 12%) were more common
than bullous changes (n = 4, 2%) in KS lesions in our
study. No vesicular formation was observed clinically in
lesions in which microscopic vesicle formation was
observed. On the other hand, a clinical bullous forma-
tion was observed in cases with microscopic bullous for-
mation. Vesicle and bulla differentiation is associated
with blister size. Growth in vesicle size by fluid accumu-
lation results in the formation of bullae [22]. Thus, in
our study, vesicles may not have been detected clinically
due to the smaller vesicle size in cases with microscopic
vesicles. Similar histopathological features of lesions with
vesicular and bullous changes in our study suggest that
these lesions represent different phases of the same
process.
Conclusions
In conclusion, the results of our study found that the
demographic data of KS cases, which demonstrated abullous pattern, was similar to that of other classic KS
cases. Histologically, these lesions were closely asso-
ciated with high stage, marked dermal edema and
enlarged lymphatic vessels. Our findings support the
idea that the vesiculobullous patterns observed during
KS develop secondary to tumorogenesis. Therefore, the
term “bullous KS” should be used as a clinical definition,
and it should be remembered that it may be present in
different histological subtypes. Clinical and histopatho-
logical recognition of vesiculobullous changes in KS is
important so that accurate data can be assimilated for
further studies.
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